EGRP News Flash - February 20, 2013
Call for Pilot and Feasability Studies by NIH-Funded Metabolomics Centers
The National Institutes of Health (NIH) Common Fund's Metabolomics Program supports a variety of initiatives for increasing national capacity in metabolomics. The Metabolomics Program recently funded three Regional Comprehensive Metabolomics Research Cores (RCMRC) to provide high-quality metabolomics services to basic, translational, and clinical investigators and promote biological and clinical application of these technologies. To stimulate interest and foster new collaborative interactions, the RCMRCs are supporting pilot and feasibility projects using metabolomics technology. The awards will support up to $50,000 in total costs per project. The maximum funding period will be one year.
The due date for the first round of applications is March 1, 2013. This solicitation provides information on the first "call for applications." It is anticipated that there will be additional opportunities to submit applications in the future.
Given the close receipt dates, interested individuals are strongly encouraged to contact the RCMRC Principal Investigators or the contacts listed in the solicitations for more information and/or to discuss potential projects.
Learn more about the call for applications through the RCMRCs:
- Eastern Regional Comprehensive Metabolomics Resource Core
- Michigan Regional Comprehensive Metabolomics Research Core
- West Coast Metabolomics Center
Learn more about the NIH Common Fund's Metabolomics Program.
For cancer epidemiology questions related to the NIH Common Fund's Metabolomics Program, contact EGRP's Mukesh Verma, Ph.D., Chief, Methods and Technologies Branch.